Pfizer's Viagra Challenged As Korea's JW Choongwae Launches ED Product In Korea
This article was originally published in PharmAsia News
Executive Summary
SEOUL - South Korea's JW Choongwae Pharmaceutical Corp. launched its new erectile dysfunction product Zepeed (avanafil) in Korea Oct. 19, ahead of approval in the U.S
You may also be interested in...
No Good News For Pharma In Korea As Most Companies See Sales Decline
Foreign and domestic companies performed poorly during the first nine months in South Korea with no positive factors on the horizon.
Korean Court Dismisses Pfizer’s Call For Protection Of Sildenafil Design
Did Hanmi’s generic Pal Pal tablets infringe Pfizer’s unique design?
Roche’s Japanese Subsidiary Chugai And Korea’s JW Choongwae Gearing Up To Develop Three New Products
For the first time since they established their joint-venture research center in Korea, JW and Chugai announced their goals for the development and sales of three globally competitive new products.